Healthcare >> Analyst Interviews >> May 22, 2001
CHRISTOPHER J. SYLVESTER is an Associate Director in the healthcare
group of UBS Warburg Equity Research. He covers the pharmaceutical
industry, with special emphasis on mid-cap pharmaceutical companies.
Prior to joining UBS Warburg, Mr. Sylvester was the mid-cap
pharmaceutical analyst at PaineWebber Incorporated and before that Mr.
Sylvester assisted in covering the pharmaceutical industry. Mr.
Sylvester holds an MS in Biotechnology from the College of William &
Mary and a BA in Biotechnology from Bucknell University. Profile
TWST: What is your outlook for specialty pharmaceuticals in general forthe next 12-18 months? What factors are part of your assessment?
Mr. Sylvester: A lot of our work in this area is in